Yahoo Web Search

Search results

  1. Rolf Martin Zinkernagel AC (born 6 January 1944) is a professor of experimental immunology at the University of Zurich. Along with Peter C. Doherty, he shared the 1996 Nobel Prize in Physiology or Medicine for the discovery of how the immune system recognizes virus-infected cells.

  2. Rolf M. Zinkernagel (born January 6, 1944, Basel, Switzerland) is a Swiss immunologist and pathologist who, along with Peter C. Doherty of Australia, received the Nobel Prize for Physiology or Medicine in 1996 for their discovery of how the immune system distinguishes virus -infected cells from normal cells.

    • The Editors of Encyclopaedia Britannica
  3. The Nobel Prize in Physiology or Medicine 1996 was awarded jointly to Peter C. Doherty and Rolf M. Zinkernagel "for their discoveries concerning the specificity of the cell mediated immune defence"

  4. Rolf M. Zinkernagel. The Nobel Prize in Physiology or Medicine 1996. Born: 6 January 1944, Basel, Switzerland. Affiliation at the time of the award: University of Zurich, Institute of Experimental Immunology, Zurich, Switzerland.

  5. Rolf M. Zinkernagel, born January 6, 1944, Basel, Switzerland. Address: Institute of Experimental Immunology, Department of Pathology, University of Zurich, University Hospital, Sternwartstrasse 2, 8091 Zurich, Switzerland. Academic Education.

    Address:
    Institute Of Experimental Immunology, ...
    1962-1968
    University of Basel, Faculty of Medicine
    1968
    National Board Examination, University of ...
    1970
    MD Thesis, University of Basel, Faculty ...
    1975
    PhD Thesis, Australian National ...
  6. Rolf M. Zinkernagel, University of Zurich, was awarded the 1996 Nobel Prize for Physiology or Medicine jointly with Peter C. Doherty (AAI '76) for "their discoveries concerning the specificity of the cell mediated immune defense."

  7. Rolf Zinkernagel entered new scientific territory by finding out, how our immune system recognises virus-ridden somatic cells. Zinkernagel made a significant contribution to the treatment of infectious diseases, as well as to the strengthening of the immune system.